Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Transpek Industry Ltd (TRANSPEK)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506687 NSE: TRANSPEK Chemicals | Small Cap | Transpek Industry Share Price
₹1,403.50 35.35 (2.58%)
As on 04-Sep'26 16:59
Transpek Industry Ltd (TRANSPEK)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506687 NSE: TRANSPEK Chemicals | Small Cap | Transpek Industry Share Price
₹1,403.50 35.35 (2.58%)
As on 04-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹784 Cr.
Current Price
₹1,403.5
52-Week Low / High
₹864 / 1,520
TTM EPS
₹69.8
TTM Sales
₹618 Cr.
Book Value per Share
₹1,390
P/E Ratio
20.10
Higher than its 5-year historical median
Industry PE
49.6
Price to Book (P/B)
1.01
Lower than its 5-year historical median
Price to Sales (P/S)
1.27
Lower than its 5-year historical median
EV/EBITDA
6.69
Lower than its 5-year historical median
Dividend Yield
1.43%
Profitability Efficiency
Return on Equity (ROE)
6.03%
Underperforms industry median
Return on Capital Employed (ROCE)
8.70%
Underperforms industry median
Return on Assets (ROA)
4.54%
Operating Profit Margin
16%
Net Profit Margin
7.35%
Gross Profit Margin
17.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-4.41%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
-1.36%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-6.34%
Asset Quality
Promoter Holding
57.27%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹771 Cr.
Equity
₹5.6 Cr.
Face Value
₹10
All Time Low / High
₹6.90 / 2695.00
Check Before You Invest
Quality
Somewhat GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Strong
Is Transpek Industry Ltd a good quality company?
Transpek Industry Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Transpek Industry Ltd performance compare with that of its Peers?
Revenue growth of Transpek Industry Ltd vs industry peers?
Transpek Industry Ltd revenue CAGR is 12.85%, compared to the industry median CAGR of 7.91%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Transpek Industry Ltd?
Promoters hold 57.27% of the Transpek Industry Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Transpek Industry Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 12.6% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transpek Industry Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 23% | 12.6% | 26.6% | 24.3% | 7.8% | 17.4% | 20.7% | 10.1% | 9.8% | 8.7% | - |
| Value Creation Index ⓘ | 0.6 | -0.1 | 0.9 | 0.7 | -0.4 | 0.3 | 0.5 | -0.3 | -0.3 | -0.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 317 | 361 | 595 | 566 | 339 | 599 | 827 | 580 | 650 | 621 | 618 |
| Sales YoY Gr. | - | 14.1% | 64.6% | -4.9% | -40% | 76.5% | 38% | -29.9% | 12.1% | -4.4% | - |
| Adj EPS ⓘ | 52.9 | 46 | 117.9 | 132.3 | 41 | 118 | 160.7 | 68.1 | 96.8 | 88.3 | 69.8 |
| YoY Gr. | - | -13% | 156.2% | 12.2% | -69% | 187.8% | 36.2% | -57.6% | 42.1% | -8.8% | - |
| BVPS (₹) ⓘ | 368.1 | 442.1 | 557.5 | 605.9 | 680 | 867.1 | 1,050.3 | 1,205.6 | 1,334.4 | 1,374 | 1,390 |
| Adj Net Profit ⓘ | 29.5 | 25.7 | 65.8 | 73.9 | 22.9 | 65.9 | 89.8 | 38.1 | 54.1 | 49.3 | 39 |
| Cash Flow from Ops. ⓘ | 47 | 7.4 | 128 | 111 | 34.4 | 47.1 | 111 | 97.8 | 135 | 78.5 | - |
| Debt/CF from Ops. ⓘ | 1.9 | 27.6 | 1.1 | 1 | 2.8 | 2.7 | 0.7 | 0.5 | 0.3 | 0.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 7.8% | 12.9% | -9.1% | -4.4% | ||||
| Adj EPS ⓘ | 5.9% | 16.6% | -18.1% | -8.8% | ||||
| BVPSⓘ | 15.8% | 15.1% | 9.4% | 3% | ||||
| Share Price | 12.6% | -8.7% | -10.7% | 2.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 19.9 | 11.4 | 23.6 | 22.7 | 6.4 | 15.3 | 16.8 | 6 | 7.6 | 6.5 | 5.1 |
| Op. Profit Mgn % ⓘ | 16.9 | 13.1 | 19.7 | 21.1 | 14.1 | 17 | 19 | 14.2 | 15.8 | 16.1 | 14.5 |
| Net Profit Mgn % ⓘ | 9.3 | 7.1 | 11.1 | 13.1 | 6.8 | 11 | 10.9 | 6.6 | 8.3 | 7.9 | 6.3 |
| Debt to Equity ⓘ | 0.4 | 0.8 | 0.5 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 123 | 156 | 112 | 111 | 160 | 104 | 97 | 140 | 117 | 128 | 41 |
| Cash Conv. Cycle ⓘ | 65 | 70 | 44 | 48 | 82 | 53 | 47 | 71 | 55 | 65 | 27 |
Valuation of Transpek Industry - Standalone
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 317 | 361 | 595 | 566 | 339 | 599 | 827 | 580 | 650 | 621 |
| Operating Expenses ⓘ + | 264 | 314 | 478 | 448 | 292 | 503 | 680 | 497 | 555 | 528 |
| Operating Profit ⓘ | 53 | 47 | 117 | 118 | 47 | 96 | 147 | 82 | 95 | 93 |
| Operating Profit Margin (%) | 16.6% | 13.0% | 19.6% | 20.8% | 13.9% | 16.0% | 17.8% | 14.2% | 14.6% | 15.0% |
| Other Income ⓘ + | 7 | 10 | 18 | 17 | 17 | 29 | 18 | 25 | 29 | 25 |
| Interest ⓘ | 9 | 12 | 19 | 16 | 10 | 11 | 19 | 14 | 12 | 8 |
| Depreciation ⓘ | 9 | 10 | 14 | 26 | 29 | 30 | 33 | 38 | 50 | 49 |
| Profit Before Tax ⓘ | 42 | 35 | 101 | 94 | 26 | 84 | 113 | 56 | 62 | 61 |
| Tax ⓘ | 12 | 9 | 36 | 21 | 2 | 19 | 29 | 17 | 13 | 16 |
| Profit After Tax | 30 | 26 | 66 | 73 | 23 | 65 | 83 | 39 | 49 | 46 |
| PAT Margin (%) | 9.5% | 7.3% | 11.1% | 12.9% | 6.9% | 10.9% | 10.1% | 6.7% | 7.5% | 7.4% |
| Adjusted EPS (₹) | 53.7 | 47.3 | 117.7 | 130.6 | 41.7 | 117.1 | 149.5 | 69.0 | 87.3 | 81.7 |
| Dividend Payout Ratio (%) | 16.80% | 19% | 17% | 9.60% | 18% | 19.20% | 18.40% | 20.30% | 22.90% | 24.50% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 206 | 247 | 311 | 338 | 380 | 484 | 587 | 673 | 745 | 767 | |
| Debt + | 70 | 180 | 120 | 77 | 71 | 105 | 63 | 30 | 29 | 32 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 34 | 54 | 59 | 52 | 36 | 56 | 54 | 46 | 64 | 69 | |
| Others Liabilities ⓘ | 77 | 85 | 108 | 121 | 112 | 118 | 183 | 217 | 162 | 140 | |
| Total Liabilities ⓘ | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 | 1,001 | 1,008 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 117 | 179 | 236 | 287 | 287 | 295 | 365 | 397 | 360 | 343 | |
| CWIP ⓘ | 13 | 56 | 33 | 19 | 14 | 16 | 24 | 6 | 5 | 5 | |
| Investments ⓘ | 131 | 144 | 149 | 118 | 142 | 196 | 238 | 321 | 328 | 317 | |
| Inventories | 37 | 46 | 56 | 50 | 37 | 66 | 65 | 64 | 67 | 50 | |
| Trade Receivables | 67 | 93 | 93 | 90 | 76 | 99 | 118 | 92 | 103 | 150 | |
| Cash Equivalents | 1 | 2 | 1 | 1 | 22 | 51 | 25 | 31 | 101 | 115 | |
| Others Assets ⓘ | 20 | 47 | 30 | 25 | 21 | 41 | 51 | 55 | 36 | 28 | |
| Total Assets ⓘ | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 | 1,001 | 1,008 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 47 | 7 | 128 | 111 | 34 | 47 | 111 | 98 | 135 | 78 |
| Cash Flow From Investing Activity ⓘ + | -31 | -103 | -45 | -33 | -17 | -70 | -13 | -32 | -30 | -38 |
| Cash Flow From Financing Activity ⓘ + | -17 | 96 | -83 | -77 | -3 | 9 | -94 | -64 | -56 | -40 |
| Net Cash Flow ⓘ | -1 | 0 | -0 | 0 | 15 | -14 | 4 | 3 | 48 | 1 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 20.23 | 11.67 | 23.55 | 22.45 | 6.49 | 15.14 | 15.59 | 6.12 | 6.87 | 6.03 |
| ROCE (%) | 22.98 | 12.62 | 26.57 | 24.27 | 7.81 | 17.43 | 20.66 | 10.11 | 9.79 | 8.7 |
| Asset Turnover Ratio | 1.1 | 0.76 | 1.02 | 0.95 | 0.57 | 0.88 | 1 | 0.63 | 0.66 | 0.62 |
| PAT to CFO Conversion(x) | 1.57 | 0.27 | 1.94 | 1.52 | 1.48 | 0.72 | 1.34 | 2.51 | 2.76 | 1.7 |
| Working Capital Days | ||||||||||
| Receivable Days | 63.10 | 80.70 | 57.40 | 59.10 | 89.10 | 53.30 | 47.90 | 66 | 54.60 | 74.30 |
| Inventory Days | 41.70 | 41.70 | 31.30 | 34.10 | 46.40 | 31.30 | 28.90 | 40.70 | 36.90 | 34.50 |
| Payable Days | 66.50 | 83.80 | 68.90 | 78 | 98.80 | 53.50 | 46.10 | 63.60 | 60.10 | 83.60 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Transpek Industry Ltd FAQs
The current trading price of Transpek Industry on 04-Sep-2026 16:59 is ₹1,403.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Sep-2026 the market cap of Transpek Industry stood at ₹783.9 Cr
The latest P/E ratio of Transpek Industry as of 03-Sep-2026 is 20.10.
The latest P/B ratio of Transpek Industry as of 03-Sep-2026 is 1.01.
The 52-week high of Transpek Industry is ₹1,520 and the 52-week low is ₹864.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transpek Industry is ₹618 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Transpek Industry Ltd is a average quality company.
The key valuation ratios of Transpek Industry Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Transpek Industry Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Transpek Industry Ltd
Transpek Industry was set up in 1965 initially for manufacturing transparent acrylic sheets. The company has grown to become one of the leading manufacturers and exporters of a range of chemicals servicing the requirements of customers from a diverse range of industries - textiles, pharmaceuticals, agrochemicals, polymers, etc.
Transpek has evolved as a ‘first time’ manufacturer of several products in India and also pioneered the development of the market for the same.
With its expertise in handling chlorine and sulphur, the company has indigenously developed a process for chlorinated chemicals like Thionyl Chloride and Chloro Acetyl Chloride. Today the capacity for thionyl chloride at Transpek is the largest outside Europe.
Transpek used to manufacture sodium hydro sulphite, safolite, safoline, zinc oxide and zinc dust. This business since has been transferred to Transpek Silox Industry, a joint venture between Transpek & Silox.
Products
• Thionyl Chloride: 15000 TPA
• Chloro Acetyl Chloride: 900 TPA
• Sulphur Dichloride: 1500 TPA
• Sulphur Monochloride: 7500 TPA
• Oleum 65% : 12000 TPA
• Sulphur Trioxide: 10000 TPA
• Sulphuric Acid: 5000 TPA
• Sulphur Dioxide: 7500 TPA
• Acid Chlorides: 1200 TPA
Milestones
• In 1989, all members of Transpek received equity shares at face value, when the market price was over 20 times.
• In 1990, the company won a turnkey project in Iran to install and commission a chemical plant valuing $12.5 million, against competition from several world players.
• 1992, Financial Express, a leading Indian business daily, declared Transpek as the ‘Best Inorganic Chemical Company’ for two consecutive years.
• In 1996 Transpek commissioned the world’s largest manufacturing facility for Thionyl Chloride outside Europe.
• In 1997, its quality management system was awarded with ISO 9002 recognition from RWTUV of Germany.
• Transpek was recognized by the Government of India as an Export House.
• In 2000, the company’s quality management system was awarded ISO 14001 recognition from RWTUV of Germany
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
